Cold Spring Harbor Laboratory and North Shore-LIJ to Form $120 Million Collaboration

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Bruce Stillman, president and CEO of CSHL, and Michael J. Dowling, president and CEO of the North Shore-LIJ Health System

Two New York institutions—Cold Spring Harbor Laboratory and the North Shore-LIJ Health System—announced a $120 million cancer research collaboration on April 2.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I have spent over 20 years running a tumor imaging metrics core at an academic cancer center. In that time, I have watched clinical trial enrollment concentrate at a relatively small number of flagship academic institutions. Unfortunately, trials do not propagate well to the community sites where most patients prefer to receive care. The explanations usually offered for why this happens have never fully accounted for what I observed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login